EBERT, Tim, Daniel E. HEINZ, Suellen ALMEIDA-CORREA, Renata CRUZ, Frederik DETHLOFF, Tibor ŠTARK, Thomas BAJAJ, Oriana M. MAUREL, Fabiola M. RIBEIRO, Silvio CALCAGNINI, Kathrin HAFNER, Nils C. GASSEN, Christoph W. TURCK, Benoit BOULAT, Michael CZISCH and Carsten T. WOTJAK. Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice. frontiers in aging neuroscience. LAUSANNE: FRONTIERS MEDIA SA, 2021, vol. 13, November 2021, p. 1-17. ISSN 1663-4365. Available from: https://dx.doi.org/10.3389/fnagi.2021.731603.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Myo-Inositol Levels in the Dorsal Hippocampus Serve as Glial Prognostic Marker of Mild Cognitive Impairment in Mice
Authors EBERT, Tim (276 Germany), Daniel E. HEINZ (276 Germany), Suellen ALMEIDA-CORREA, Renata CRUZ, Frederik DETHLOFF (276 Germany), Tibor ŠTARK (703 Slovakia, belonging to the institution), Thomas BAJAJ, Oriana M. MAUREL (380 Italy), Fabiola M. RIBEIRO, Silvio CALCAGNINI (380 Italy), Kathrin HAFNER (276 Germany), Nils C. GASSEN (276 Germany), Christoph W. TURCK (276 Germany), Benoit BOULAT, Michael CZISCH (276 Germany) and Carsten T. WOTJAK (276 Germany, guarantor).
Edition frontiers in aging neuroscience, LAUSANNE, FRONTIERS MEDIA SA, 2021, 1663-4365.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.702
RIV identification code RIV/00216224:14110/21:00122834
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3389/fnagi.2021.731603
UT WoS 000726118100001
Keywords in English spatial memory; biomarker; MRS; MCI; gliaastrocytes; microgliamyo-inositol
Tags 14110516, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/2/2022 08:39.
Abstract
Dementia is a devastating age-related disorder. Its therapy would largely benefit from the identification of susceptible subjects at early, prodromal stages of the disease. To search for such prognostic markers of cognitive impairment, we studied spatial navigation in male BALBc vs. B6N mice in combination with in vivo magnetic resonance spectroscopy (H-1-MRS). BALBc mice consistently showed higher escape latencies than B6N mice, both in the Water Cross Maze (WCM) and the Morris water maze (MWM). These performance deficits coincided with higher levels of myo-inositol (mIns) in the dorsal hippocampus before and after training. Subsequent biochemical analyses of hippocampal specimens by capillary immunodetection and liquid chromatography mass spectrometry-based (LC/MS) metabolomics revealed a higher abundance of glial markers (IBA-1, S100B, and GFAP) as well as distinct alterations in metabolites including a decrease in vitamins (pantothenic acid and nicotinamide), neurotransmitters (acetylcholine), their metabolites (glutamine), and acetyl-L-carnitine. Supplementation of low abundant acetyl-L-carnitine via the drinking water, however, failed to revert the behavioral deficits shown by BALBc mice. Based on our data we suggest (i) BALBc mice as an animal model and (ii) hippocampal mIns levels as a prognostic marker of mild cognitive impairment (MCI), due to (iii) local changes in microglia and astrocyte activity, which may (iv) result in decreased concentrations of promnesic molecules.
Links
MUNI/A/1249/2020, interní kód MUName: Základní výzkum v oblasti farmakokinetiky, neurobiologie závislostí a aplikovaný výzkum v oblasti personalizované farmakoterapie v onkologii (Acronym: SV_Farmakologie2021)
Investor: Masaryk University
PrintDisplayed: 24/7/2024 12:19